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Neural crest stem cells arise within the central nervous system but
then undergo an epithelial-to-mesenchymal transition to migrate
away and contribute to the peripheral nervous system and cranio-
facial skeleton. Here we show that DNA methyltransferase 3B
(DNMT3B) is responsible for the loss of competence of dorsal neural
tube cells to generate emigrating neural crest cells. DNMT3B knock-
down results in up-regulation of neural crest markers, prolonged
neural crest emigration, and subsequent precocious neuronal dif-
ferentiation of the trigeminal ganglion. We find that DNMT3B
binds to the promoter of Sox10, known to be important for neural
crest emigration and lineage acquisition. Bisulfite sequencing fur-
ther reveals methylation of the Sox10 promoter region upon ces-
sation of emigration in normal embryos, whereas this mark is
reduced after DNMT3B loss. Taken together, these results reveal
the importance of DNA methylation in regulating the ability of
neural tube cells to produce neural crest cells and the timing of
peripheral neuron differentiation.
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The neural crest is a multipotent stem cell population, uniqueto vertebrates, that contributes to a wide variety of deriva-
tives, including sensory and autonomic ganglia of the peripheral
nervous system (PNS), cartilage and bone of the face, and pig-
mentation of the skin. Neural crest progenitors arise at the neural
plate border, and after neurulation reside within the dorsal aspect
of the central nervous system (CNS). They then undergo an
epithelial-to-mesenchymal transition (EMT) and delaminate from
the neural tube as migratory mesenchymal cells that navigate to
diverse and sometimes distant locations. The timing of onset and
cessation of neural crest emigration from the CNS is stereotypic. In
birds, neural crest cells initiate EMT shortly after neural tube
closure and cease emigration 1 d later. Control of proper neural
crest production and migration is critical for normal development,
with dysregulation of these processes leading to birth defects and
peripheral neuropathies.
Initiation of neural crest emigration has been well studied. At
trunk levels, it depends on appropriate levels of BMP signaling to
regulate the G1/S transition of emigrating neural crest cells in
aWnt-dependent manner (1). At the level of transcription, Snail2,
Sox10, and Sip1 play important roles in EMT in both neural crest
and cancer cells (2–4); for example, overexpression of Sox10
causes ventral neural tube cells to aberrantly undergo EMT and
become migratory (5). In contrast, the mechanisms that restrict
neural crest production over time are poorly understood. Single
cell lineage analysis has shown that individual precursor cells can
give rise to both neural crest and neural tube derivatives (6, 7).
This raises the intriguing possibility that unknown factors, such as
epigenetic modifiers, may progressively limit the competence of
presumptive CNS cells to produce neural crest cells, thereby
influencing the balance of neural tube vs. neural crest cell fate.
Consistent with this possibility, we previously showed that
a DNA methyltransferase (DNMT3A) functions early to re-
press neural genes Sox2 and Sox3 in the presumptive neural
crest, as a prerequisite for neural crest specification (8). DNA
methyltransferases DNMT3A and 3B are essential for de novo
methylation by catalyzing the transfer of a methyl group to cyto-
sine residues on DNA (9). Both play important roles in de-
velopment and disease (10, 11). DNMT3B null embryos exhibit
rostral neural tube defects and growth impairment (12). More-
over, mutations in human DNMT3B are found in immunodefi-
ciency-centromeric instability-facial anomalies (ICF) syndrome,
comprising facial abnormalities, neurologic dysfunction, and other
defects (13) suggestive of abnormal neural crest development.
Similarly, DNMT3 knockdown in zebrafish causes defects in cra-
niofacial structures and improper neurogenesis (14). DNMT3B
loss in human ES cells accelerates neural and neural crest dif-
ferentiation and increases the expression of neural crest genes
(Pax3/7, FoxD3, Sox10, and Snail2) (15). Taken together, these
data are consistent with an important role for DNMT3B in neural
crest development.
Here we tested the developmental function of DNMT3B in
avian embryos, owing to their accessibility for transient knock-
down and similarity to humans at early stages of development.
Our results indicate that loss of DNMT3B prolongs neural crest
production by the neural tubes and up-regulates the expression
of key neural crest transcription factors such as Sox10. We show
that DNMT3B directly binds to and methylates the Sox10 pro-
moter in neural tube progenitors, resulting in cessation of neural
crest EMT. Thus, DNMT3B is involved in regulating the dura-
tion of neural tube cell competence to produce migratory neural
crest cells.
Significance
Mutations of DNA methyltransferase 3B (DNMT3B) result in
facial abnormalities and neurologic defects in humans related
to abnormal neural crest development. To address the un-
derlying mechanism, we tested the role of DNMT3B using loss-
of-function and molecular analyses in chick embryos. Neural
crest cells initially form within the central nervous system (CNS),
then migrate away to form elements of the facial skeleton and
peripheral nervous system (PNS). Our results show that DNMT3B
acts by directly methylating the promoter region of the neural
crest gene Sox10 in neural tube progenitors, thereby inhibiting
its transcription. This in turn influences the duration of neural
crest production by the CNS, such that DNMT3B loss causes
overproduction of neural crest cells and premature neuronal
differentiation in the PNS.
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Results
DNMT3B Expression During Neural Crest Induction and Migration.We
identified several epigenetic factors, including DNMT3B, in
screens for neural crest genes (16, 17). To assess its functional
significance, we first examined DNMT3B transcript expression
from gastrulation to the formation of neural crest derivatives,
focusing on the cranial neural crest region in chicken embryos.
The results show that Dnmt3b is expressed broadly at gastrula
stages throughout the neural plate and its border where neural
crest cells are induced (Fig. 1). In addition, Dnmt3b is sub-
sequently expressed in the dorsal neural tube and migratory
neural crest. Initially expressed throughout the neural tube at
stage 8, it becomes restricted to the dorsal portion by stage 10.
In migrating neural crest cells, Dnmt3b colocalizes with HNK-1
immunostaining.
Loss of DNMT3B Causes Prolonged Neural Crest Production by Neural
Tubes Without Affecting Specification.As its paralog DNMT3A (8)
affects neural crest specification, we first examined whether
DNMT3B acted similarly. Using two different fluorescein-tagged
antisense morpholino oligomers (3B MO and 3B MO2) to block
translation of DNMT3B protein, we examined the effects of its
loss of function on early neural crest gene expression. Morpho-
linos were electroporated onto one side of stage 4 embryos, with
the contralateral side serving as an internal control. No changes
were noted in expression of neural crest marker Sox10 shortly
after neural tube closure, suggesting that loss of DNMT3B had
no effect on initial neural crest specification or early migration
(Fig. S1A).
To test whether DNMT3B might play a later role, we per-
formed a similar experiment but at later stages. Morpholinos
were introduced into one side of the embryo in ovo at stage 8, as
the neural folds were elevating, and the effects on neural crest
markers Sox10 and Snail2 during migratory stages were evalu-
ated. As before, no alterations were observed at the onset of
neural crest migration (stages 9–10; Fig. S1A); however, toward
the end of migration (late stages 11–12), loss of DNMT3B
appeared to cause excess and/or prolonged emigration of neural
crest cells from the neural tube. Under normal conditions, Sox10
and Snail2 come on shortly before the initiation of neural crest
migration and are maintained on migrating neural crest cells,
and are then turned off in the dorsal neural tube after stage
11, concomitant with cessation of emigration. After DNMT3B
knockdown, however, Sox10- or Snail2-positive neural crest cells
appeared to continue emerging from the morpholino-treated
side of the embryo but not from the control side, where they
were observed only some distance away from the neural tube
(Fig. 2 A, D, and F). In contrast, similar injections of control
morpholino (Con MO) resulted in equivalent migratory patterns
on both sides of the embryo, with cessation of emigration by
stage 12 (Fig. 2 A, C, and E). Sox2 and Sox3 apparently were
unaffected by DNMT3B knockdown (Fig. S1B).
To demonstrate specificity, we performed rescue experiments
in which DNMT3B morpholino together with an expression
vector containing a DNMT3B coding sequence were introduced
at stage 8 (Fig. 2 B and D). Using 1.0 μg/μL of DNMT3B ex-
pression construct coelectroporated with 3B MO significantly
(P < 0.05) rescued the phenotype compared with 3B MO plus
empty vector. Using a lower concentration (0.5 μg/μL) of DNMT3B
construct plus 3B MO led to a slight, but not significantly dif-
ferent (P = 0.38), improvement in severity (Fig. 2 B and D).
To definitively test whether neural crest emigration was pro-
longed, we labeled neural tubes with the lipophilic dye DiI after
normal termination of cranial neural crest cell emigration (stage
12). DiI labeling of control MO-treated neural tubes at this stage
yielded DiI label confined to the neural tube (Fig. 2F) and not
present in migrating neural crest cells at midbrain/rostral hind-
brain levels. In contrast, in 3B MO-treated embryos, DiI-labeled
migrating neural crest cells continued to emigrate from the
neural tube at these axial levels on the MO-injected side (Fig.
2F). A few DiI-labeled cells were seen on the contralateral side
as well, likely representing cells generated from the MO-treated
side that crossed the midline, given that ∼20% of neural crest
cells “cross” to the opposite side (6). These results demonstrate
that DNMT3B loss leads to extended production of cranial
neural crest cells beyond the time when emigration normally
would cease in control embryos.
Multiplex Analysis Shows that Loss of DNMT3B Up-Regulates Neural
Crest Specifier Genes, While Down-Regulating Dorsal Neural Tube
Genes. To consider global changes in gene expression caused
by DNMT3B knockdown, we performed multiplex NanoString
analysis to simultaneously monitor and quantify 70 transcripts
involved in neural crest and tube development, as well as cell
proliferation and cell death. NanoString is exquisitely quantita-
tive because it does not require RNA extraction or enzymatic
reaction, thus allowing accurate quantitation of transcript levels.
Individual half dorsal neural tubes from DNMT3B knockdown
embryos were analyzed at stage 12 by comparing the morpho-
lino-electroporated and uninjected sides of the same embryo
(Fig. 3A). Given that there are no significant differences between
the two sides of Ctrl-MO–treated embryos (4, 18) with a <20%
variation, we defined 30% variation as our cutoff for statistical
significance (Fig. 3A, red and green dotted lines). DNMTs are
thought to inhibit transcription by methylating the promoter
region of target genes; thus, genes up-regulated as a conse-
quence of DNMT3B loss represent potential direct targets.
NanoString data analysis averaged over six embryos showed
that neural crest specifier genes TfAp2A, Sox9, Sox10, Snail2, and
FoxD3 were all significantly up-regulated as a result of DNMT3B
knockdown (Fig. 3B). In contrast, Ncad was down-regulated
(Fig. 3B), and expression of cell proliferation (Pcna), cell death
(Perp and Bcl2), and housekeeping (Eef1A1, Gapdh) genes was
unchanged between the injected and uninjected sides.
Fig. 1. DNMT3B is expressed in the neural crest territory. Shown is the ex-
pression pattern of DNMT3B in stage 4–14 chicken embryos by in situ hy-
bridization. During stages 4–8, DNMT3B is expressed throughout the neural
plate (green arrowhead) and neural plate border (blue arrowhead). During
migratory stages (stages 10–11), expression of DNMT3B is restricted to the
dorsal neural tube and migratory neural crest cells (black arrowhead). Using
HNK-1 staining (red) as a marker for migrating neural crest cells, DNMT3B
colocalizes with HNK-1–positive migrating neural crest cells as well as in
neural crest derivatives. DNMT3B is no longer expressed at stage 14. The
dashed line indicates the level of cranial region cross-sectioned.
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Loss of DNMT3B Results in Excess Migrating Neural Crest and
Premature Differentiation of Trigeminal Ganglia. To examine later
effects caused by loss of DNMT3B, we collected embryos at
stages of neural crest migration and examined expression of the
migratory neural crest marker HNK-1. Compared with the con-
trol side of the same embryo, the DNMT3B knockdown side had
many more neural crest cells, as observed in both whole-mount
and transverse sections (Fig. 4A). Quantification of the increase
in migratory neural crest cells using two concentrations of 3B MO
showed significant differences compared with control MO treated
embryos (Fig. 4B). Similarly, excess Sox10-expressing cells were
detected by in situ hybridization on the DNMT3B knockdown
side at stage 13 (Fig. 4C).
DNMT3A and 3B paralog expression patterns have some
overlap, raising the possibility that they may act in a functionally
redundant fashion. However, knockdown of DNMT3A alone had
little effect on neural crest emigration when introduced at stage 8
(Fig. 4D). In contrast, dual knockdown of DNMT3A and 3B had
profound effects on neural crest production (Fig. 4D), comparable
to or even more penetrant than those observed with 3BMO alone.
This suggests that the two paralogs are likely to play temporally
distinct roles, with DNMT3A primarily acting early (8) and
DNTM3B acting toward the end of neural crest emigration.
To examine effects on neural crest differentiation, we stained
embryos with TUJ1 as a marker of neuronal differentiation. Sur-
prisingly, we observed early condensation of the trigeminal
ganglion and premature neuronal differentiation on the 3B MO-
treated side of the embryo (Fig. 5). Whereas neuronal differenti-
ation was just beginning on the uninjected side or in control
morpholino at late stage 13, well-differentiated and condensed
trigeminal ganglia with obvious ophthalmic and maxillo-mandibular
lobes were present on the 3B MO-treated sides.
DNMT3B Binds to and Methylates the Sox10 Promoter. Our Nano-
String and in situ data raise the intriguing possibility that
DNMT3B could regulate de novo methylation and subsequent
repression of genes involved in the maintenance of neural crest
progenitors and EMT, thus preventing continuous neural crest
formation. CpG island promoters were recently shown to be
largely hypomethylated, even when silenced on different tissues
and developmental stages in many vertebrate models (19); thus,
we examined the presence of CpG islands in the promoter
Fig. 2. Loss of function of DNMT3B causes prolonged migration of neural crest cells using Sox10, Snail2, and DiI as markers. (A) Electroporation of mor-
pholinos against DNMT3B (3B MO and 3B MO2) caused prolonged emigration of neural crest cells compared with control morpholino (Con MO). Cranial
neural crest cells marked by Sox10 or Snail2 appear to keep emigrating from the neural tube for longer periods (arrow) on the side electroporated with
3B MO compared with the internal control side. Embryos electroporated with Con MO show similar expression on both sides. (B) Rescue experiments were
performed by coelectroporating 3B MO with two different concentrations of the overexpressing vector containing the DNMT3B coding sequence
(0.5DNMT3B and 1.0DNMT3B). Effects were analyzed by in situ hybridization for detection of Sox10 expression. An asterisk indicates the side of injection.
(C) Quantitation of percentage of 3B MO- or Con MO-treated embryos with either a strong or a mild prolonged emigration phenotype using Sox10 or Snail2
as markers. (D) Quantitation of the phenotype of rescue experiments of 3B MO plus empty vector, 0.5 μg/μL DNMT3B (0.5DNMT3B) or 1.0 μg/μL DNMT3B
vector (1.0DNMT3B). Treated embryos were characterized as having a strong or a mild prolonged emigration phenotype using the Sox10marker. *P < 0.05, χ2
contingency test. Numbers in the graphs represent the numbers of analyzed embryos. (E) Transverse sections of embryos treated with 3B MO and those
treated with Con MO. Sox10-positive neural crest cells continue to emigrate out of the neural tube (arrows) on the 3B MO-treated side compared with the
internal control side. In Con MO-treated embryos, emigration has ceased on both sides. (Inset) FITC with morpholino incorporation. An asterisk indicates the
side of MO injection. (F) Embryos were electroporated with MO at stage 8 into the right side of the neural tube (asterisk), and DiI was used to label the entire
neural tube during early stage 12, by which time emigration ceased in normal embryos. Embryos were collected and sectioned at stage 13. Prolonged
emigration was observed (arrows) on the side treated with 3B MO, whereas no emigration was observed on the uninjected side or the Con MO-treated side.
Four of the nine embryos treated with 3B MO and none of the seven embryos treated with Con MO had a prolonged emigration phenotype.
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regions of neural crest specifier genes up-regulated after DNMT3B
loss. Interestingly, only Sox10 lacks CpG islands in its promoter
region, whereas these islands are present in other neural crest
specifier genes, including Snail2 and FoxD3 (Fig. S2). Thus, Sox10
is a likely candidate for promoter methylation by DNMT3B.
To test this idea in vivo, we used microChIP (18), followed by
quantitative PCR (qPCR), to assess whether Sox10 is a direct
target of DNMT3B. To this end, embryos were electroporated
with a construct encoding full-length DNMT3B tagged with
FLAG at the N terminus. After development to stage 12, dorsal
neural folds were dissected and processed for microChIP. The
data show that DNMT3B associates with the promoter region of
Sox10, compared with gene desert regions of chromosomes 1 and
2 serving as control regions (Fig. 6A). In contrast, the Snail2
promoter exhibited only a low level of occupation with DNMT3B
compared with Sox10. Similarly, DNMT3B failed to bind to the
regulatory region of FoxD3 (Fig. S3), suggesting that Snail2 and
FoxD3 are indirect targets. These findings definitively show that
DNMT3B directly binds to and represses the promoter region of
Sox10, thereby shutting down neural crest production by the CNS.
We next performed bisulfite sequencing to provide insight into
the CpG methylation pattern of the Sox10 promoter region in
normal and MO-treated dorsal neural tubes at stage 13. The
results show that Sox10 is highly methylated on the control side,
and that 3B MO leads to an 18% reduction in the content of
methylated CpGs on Sox10. In contrast, we found no differences
in methylated CpGs between the 3B MO injected and uninjected
sides on the Snail2 promoter region (Fig. 6B). Accordingly, we
propose a mechanism whereby Sox10 acts as a “master regula-
tor” whose shutdown is necessary for the termination of neural
crest emigration. In turn, the up-regulation of Sox10, as a con-
sequence of 3B MO treatment, induces the demethylation of
other neural crest genes, such as Snail2 and FoxD3, and their
concomitant up-regulation.
Discussion
Long-term repression plays an important part in the programming
of gene expression profiles in developing organisms. In this regard,
de novo DNA methylation may be one of the main epigenetic
marks used for cell fate restriction of progenitor cells during
differentiation. The paralogs DNMT3A and 3B are both im-
plicated in de novo DNA methylation, with some overlapping
and other distinct functions. For example, we have shown that
DNMT3A plays an important role during neural crest specifi-
cation by acting as a molecular switch mediating the neural
tube-to-neural crest fate transition (8). DNMT3A promotes
neural crest specification by repressing, via promoter DNA
methylation, neural genes like Sox2 and Sox3 in the neural crest
territory, thus determining whether a cell becomes part of the
CNS or PNS. In contrast to DNMT3A, DNMT3B lacks a function
at this early stage; however, mutations in human DNMT3B result
in ICF syndrome, in which patients exhibit facial abnormalities
(13), suggesting a defect related to abnormal later neural crest
development.
What regulates the spatial and temporal progression of the
genetic program underlying development in such an exquisiteFig. 3. Multiplex NanoString analysis shows that the neural crest specifier
genes Snail2, Sox9/10, and FoxD3 are up-regulated on loss of DNMT3B,
whereas Ncad is down-regulated. (A) NanoString analysis of each half dorsal
neural tube from a representative embryo revealing genes up-regulated and
down-regulated by DNMT3B knockdown. The injected side of 3B MO-treated
embryos shows >25% up-regulation (above the red dotted diagonal
line) of neural crest specifier genes Sox10, Sox9, Snail2, TfAp2A, and FoxD3,
and >25% down-regulation (below the green dotted diagonal line) of type I
cadherin Ncad. (B) Bar graph showing the mean ± SD log expression ratio
(between injected and uninjected sides) of six representative 3B MO-treated
embryos. Asterisks indicate significant differences (P < 0.05) on the injected
side compared with the uninjected side, analyzed using the Student t test.
Fig. 4. DNMT3B knockdown results in extra migratory neural crest cells. (A)
Embryos electroporated with 3B MO or Con MO were immunostained with
anti-HNK1 antibody and sectioned. The 3B MO-injected sides of the embryos
(asterisk) show increased numbers of HNK1-positive neural crest cells in both
whole-mount and transverse section views. (B) Quantitation of the percent-
age of 3B MO-treated or Con MO-treated embryos with either a strong
or mild phenotype of generating extra migrating neural crest cells on the
electroporated side vs. the internal control side. n = 13 for 3B MO 1.5 mM;
n = 8 for Con MO 1.5 mM; n = 9 for 3B MO 2.5 mM; n = 8 for Con MO 2.5 mM.
*P < 0.05, χ2 contingency test. (C) Embryos collected at stage 13 continue to
exhibit extra neural crest cells (arrow; n = 5/7) using Sox10 as a marker on the
3B MO-treated side (asterisk) vs. the control side in both whole-mount and
section views. (D) Embryos electroporated with DNMT3B MO, 3AMO, or 3A+3B
MOs were assayed for Sox10 expression by whole-mount in situ hybridization
and sectioned. Whereas minor or no effect on the Sox10 expression were
observed for 3A MO alone, the double knockdown appeared similar to
3B MO knockdown, causing excess neural crest cell emigration (blue arrow).
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manner? Our results suggest that de novo DNA methylation,
exerted by both DNMT3A and 3B, plays a dual role in the
programs governing neural crest development. First, DNMT3A
appears to limit the spatial boundary between neural crest versus
neural tube progenitors, repressing the expression of neural
markers in the neural crest forming territory. Second, DNMT3B
appears to restrict the temporal window during which progeni-
tors in the dorsal neural tube are competent to undergo EMT
and produce neural crest cells. Thus, interfering with DNMT3A
or 3B results in defects in PNS formation, but in separate tem-
poral windows of neural crest development.
Our results demonstrate that de novo DNA methylation of the
Sox10 promoter region, exerted by DNMT3B, is required for
cessation of cranial neural crest emigration. Interestingly, a re-
cent paper (20) has shown that ectopic expression of Sox10 alone
is sufficient to reprogram fibroblast cells in vitro to assume a
neural crest identity. These authors further show that induction
of these cells via Sox10 causes DNA demethylation of other
neural crest genes, such as FoxD3, which are highly methylated in
normal fibroblasts. Consistent with this, we show that the normal
function of DNMT3B at the conclusion of cranial neural crest
emigration is to shut down Sox10, a positive regulator of other
neural crest genes like FoxD3 and Snail2. Loss of DNMT3B
during neural crest development in vivo thus results in abnormal
maintenance of Sox10, which indirectly leads to up-regulation of
the other neural crest markers and aberrant continuation of EMT.
A recent study in mice using neural crest-specific conditional
deletion of DNMT3B failed to detect obvious defects in neural
crest migration or differentiation into craniofacial and cardiac
structures (21). One possible explanation for the difference from
our results is that the neural crest defect in DNMT3B mutant
mice may be related to a requirement for this protein before
Wnt1-driven cre expression or in neighboring cell types. Alter-
natively, the difference may simply reflect species-specific dif-
ferences, given that chicks lack DNMT3L, which is present in
mice. Because DNMT3A and 3B are paralogs, it might not be
surprising that each paralog has assumed slightly different roles
in different species. DNMT3A and 3B are not redundant during
neural crest development in chicks, but exhibit different and
somewhat overlapping patterns in mice. Although DNMT3B null
mice exhibit mostly normal neural crest development, Jacques-
Fricke et al. (21) described ectopic migrating neural crest cells
dispersed dorsal to the normal neural crest streams. This is
similar to the prolonged emigration of neural crest cells that we
observed in our 3B MO-treated chicken embryos, which results
in abnormally migrating neural crest cells. This may be a less
obvious phenotype in the null mice, considering that it is not
possible to compare control and experimental sides in the same
embryo as can be done in chicks.
In addition to de novo DNA methytransferases, other epige-
netic regulators, including histone demethylases and histone
Fig. 5. DNMT3B knockdown results in premature differentiation of the tri-
geminal ganglia. The right half (asterisk) of each embryo was electroporated
with 3B MO, 3B MO2, or Con MO (FITC). TUJ1 (red) served as a marker for
neuronal differentiation in the forming trigeminal ganglia. Premature
differentiation of the trigeminal ganglia (well-condensed ganglia with both
ophthalmic and maxillo-mandibular lobes) was observed in the 3B MO-
treated sides of the embryos compared with control sides, which showed
normal ganglion aggregation. Four of six embryos treated with 3B MO,
four of six embryos treated with 3B MO2, and none of six embryos treated
with Con MO show premature differentiation of the trigeminal ganglia.
Fig. 6. DNMT3B binds directly to the promoter regions of Sox10 and
methylates CpGs to repress its expression. (A) Embryos were electroporated
with a construct encoding exogenous DNMT3B with a FLAG tag on its
N terminus. Micro ChIP was performed to detect the occupancy of FLAG-
tagged DNMT3B on the promoter regions of Sox10 and Snail2. The y-axis
represents fold enrichment compared with IgG, and the x-axis represents the
promoter regions of Sox10, Snail2, and two negative control regions that
are in gene desert regions of chromosome 1 (Chr1nc) and chromosome 2
(Chr2nc). The results show high occupancy of DNMT3B-FLAG at the promoter
of Sox10 at stage 12, but no occupancy on the control regions and low levels
for the Snail2 promoter. Values in the graph are mean ± SD of a represen-
tative experiment. (B) Bisulfite sequencing profiles of CpG methylation on
the Sox10 and Snail2 promoters from DNMT3B MO-treated and control
dorsal neural tubes at stage 13. CpGs sequences are shown with filled
(methylated) and open (unmethylated) circles. The numbers on the profiles
represent the percentages of methylated CpGs.
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deacetylases, also have been shown to play a crucial role in
regulating the timing of neural crest specification or migration
(22, 23). Histone demethylases, such as members of the Jumonji
family, revert histone methylation (24). In neural crest devel-
opment, JmjD2A (also known as KDM4A) regulates neural crest
specification (18). JmjD2A is expressed in the neural crest ter-
ritory during neural crest specification, and its loss of function
causes dramatic down-regulation of neural crest genes such as
Sox10, Snail2, and FoxD3. In vivo ChIP assays have revealed
a direct interaction of JmjD2A with Sox10 and Snail2 promoter
regions (18). JmjD2A is required for the demethylation of
H3K9me3 at the promoter of Sox10 and Snail2 genes to allow
neural crest specification. Moreover, a histone deacetylace
(HDAC) repression complex plays an essential role in regulating
neural crest migration. Premigratory neural crest cells from the
dorsal neural tube undergo EMT to acquire migratory properties
and travel to distant locations. The transcriptional repressor
Snail2 has been reported to directly repress the adhesion mole-
cule Cadherin6B in cranial premigratory neural crest cells (25–
27). Epigenetic regulation plays a critical role in this repression
(4). In particular, an interaction between PHD12, a member of
the histone deacetylase complex, and SNAIL2 makes it possible
to recruit the repressive complex SIN3A/HDAC to the Cad6B
promoter region and, as a result, turn off Cad6B transcription via
histone deacetylation to allow neural crest cells to gain migratory
property (4). Taken together, this body of work demonstrates
that epigenetic regulators influence many aspects of neural crest
formation at different times and places.
Materials and Methods
In Ovo Electroporation. Embryos were electroporated at stage 4 or 8 as de-
scribed previously (28), using DNMT3B morpholino (3B MO, over ATG codon:
CGAGGCTCGTTACCATGCTCATCGC), DNMT3B morpholino 2 (3B MO2; up-
stream of ATG: GAACGGAGTGATGACAATGATACCT), or control morpholino
(Con MO; CCTCTTACCTCAGTTACAATTTATA). DNMT3A MO (8) was used for
some experiments. For rescue experiments, the construct included the cod-
ing region of DNMT3B-Flag in a pCI-IRES-H2BRFP vector. For each embryo,
1 mMMO + 0.5 μg/μL DNA was used for knockdown experiments, and 1 mM
MO + 0.5 or 1 μg/μL DNA was used for rescue experiments. The embryos
were then incubated until they reached the indicated stage of analysis.
In Situ Hybridization.Whole-mount chick in situ hybridization was performed
as described previously (29).
Immunohistochemistry. For immunohistochemistry analyses, anti-TUJ1 (Covance)
was diluted 1:250, and anti-HNK1 was diluted 1:10. Secondary antibodies
against the primary antibody subtype were conjugated to Alexa Fluor 488,
568, or 350 dyes (Molecular Probes). Images were obtained with a Zeiss
Axioskop2 microscope.
NanoString nCounter. Half-dorsal neural folds of 3BMO-treated embryos were
dissected in lysis buffer (Ambion RNAqueous-Micro Isolation Kit) at stage 12.
RNA lysateswere hybridized to the probe set and incubatedovernight at 65 °C,
then washed and eluted following procedures detailed in the nCounter Prep
Station Manual and counted with an nCounter Digital Analyzer.
Chromatin Immunoprecipitation. Embryoswere electroporatedwith aDNMT3B-
FLAG–containing vector. Dorsal neural tubes from embryos at stage 12 were
dissected, cells were dissociated, cross-linked, and sonicated as described
previously (18). Samples were evenly split among polyclonal anti-FLAG (Sigma-
Aldrich), anti-IgG (Abcam), and input. Antibodies with protein A magnetic
beads (Life Technologies) were incubated with the sonicated protein–DNA
complex. Samples were washed, eluted, and reverse cross-linked. The final
DNA pulldown was purified and served as a template for quantitative PCR.
Bisulfite Sequencing. Bisulfite treatment and sample recovery were carried
out with the EpiTect Plus Bisulfite Conversion Kit (Qiagen) following the
manufacturer’s instructions. In brief, six dorsal neural tubes from control or
3B MO-treated sides were lysed and bisulfite-converted. The DNA thus-
obtained was recovered in an EpiTect spin column. Two sets of nested pri-
mers were used to amplify by PCR the promoter regions of Sox10 and Snail2
genes from the bisulfite-converted DNA. The obtained product were gel-
purified and cloned into the pGEM-T Easy Vector (Promega). Individual
clones were sequenced.
Further experimental details are provided in SI Materials and Methods.
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